• Immunome Stock Up 32% in a Month: Here's What You Should Know Zacks Investment Research Fri, 10 Jul 2026 14:03:45 GMT
• Form 4 Immunome Inc For: 9 July By Investing.com Investing.com South Africa Fri, 10 Jul 2026 02:44:20 GMT
• Immunome CBO Horn Kinney sells $27,300 in stock By Investing.com Investing.com Nigeria Thu, 09 Jul 2026 22:40:04 GMT
• form 4 immunome inc for: 9 july by investing.com Investing.com Canada Thu, 09 Jul 2026 21:47:41 GMT
• Immunome Inc. (IMNM) CBO exercises options and sells 1,092 shares Stock Titan Thu, 09 Jul 2026 21:39:01 GMT
• Why Immunome (IMNM) Is Up 11.7% After FDA Accepts Varegacestat NDA For Desmoid Tumors simplywall.st Thu, 09 Jul 2026 14:34:06 GMT
• H.C. Wainwright reiterates Immunome stock rating on FDA filing By Investing.com Investing.com Nigeria Thu, 09 Jul 2026 11:46:08 GMT
• LifeSci Capital Maintains Immunome(IMNM.US) With Buy Rating, Maintains Target Price $40 富途牛牛 Wed, 08 Jul 2026 19:16:59 GMT
• FDA Accepts Immunome's NDA for Varegacestat in Desmoid Tumors, Setting Up an April 2027 Decision Oncodaily Wed, 08 Jul 2026 17:22:09 GMT
• Immunome Clears Key Regulatory Milestone as Lead Drug Goes Under FDA Review Benzinga Wed, 08 Jul 2026 17:18:49 GMT
• Immunome granted FDA review for tumor candidate (IMNM:NASDAQ) Seeking Alpha Wed, 08 Jul 2026 13:52:40 GMT
• FDA accepts Immunome NDA for desmoid tumor treatment varegacestat Investing.com Wed, 08 Jul 2026 12:51:40 GMT
• Immunome Announces U.S. FDA Acceptance of New Drug Application for Varegacestat for the Treatment of Adults with Desmoid Tumors Caledonian Record Wed, 08 Jul 2026 11:32:42 GMT
• Price-Driven Insight from (IMNM) for Rule-Based Strategy Stock Traders Daily Wed, 08 Jul 2026 04:52:02 GMT
• immunome reports inducement grants under nasdaq listing rule 5635(c)(4) - july 7, 2026 BioSpace Wed, 08 Jul 2026 03:36:51 GMT
• Immunome director Isaac Barchas sells $2.4m in shares, price $24.11-$24.20 Investing.com Wed, 08 Jul 2026 00:06:21 GMT
• Form 4 Immunome Inc For: 7 July By Investing.com Investing.com Nigeria Tue, 07 Jul 2026 23:41:17 GMT
• Form 144 Immunome Inc. For: 7 July By Investing.com Investing.com India Tue, 07 Jul 2026 23:13:23 GMT
• Entity tied to Immunome (IMNM) director sells 100K shares Stock Titan Tue, 07 Jul 2026 23:03:20 GMT
• Immunome CMO Robert Lechleider sells $1.24m in company stock Investing.com Tue, 07 Jul 2026 22:46:10 GMT
• Immunome (IMNM) CMO exercises 55K options and sells 55K shares under 10b5-1 plan Stock Titan Tue, 07 Jul 2026 21:42:37 GMT
• Immunome Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Business Wire Tue, 07 Jul 2026 20:02:00 GMT
• IMNM (Nasdaq) affiliate filings report multiple share sales, including 100,000-share entries Stock Titan Mon, 06 Jul 2026 21:38:15 GMT
• Immunome's $4.39 Million Insider Sale: A Pre-Planned Exit Amidst Robust Pipeline Momentum Kavout | AI Sat, 04 Jul 2026 06:18:59 GMT
• Form 4 Immunome Inc For: 2 July By Investing.com Investing.com Nigeria Fri, 03 Jul 2026 01:16:50 GMT
• Immunome director Barchas sells $4.39m in common stock By Investing.com Investing.com South Africa Fri, 03 Jul 2026 00:54:30 GMT
• Director-linked entities trim Immunome (IMNM) stake with 201,050-share sale Stock Titan Fri, 03 Jul 2026 00:53:11 GMT
• IMNM (Nasdaq: IMNM) Rule 144 entries show 100,000-share block Stock Titan Thu, 02 Jul 2026 20:43:23 GMT
• Form 144 Immunome Inc. For: 2 July By Investing.com Investing.com Canada Thu, 02 Jul 2026 16:23:31 GMT
• IMNM (NASDAQ: IMNM) affiliate files to sell 55,000 shares on 07/02/2026 Stock Titan Thu, 02 Jul 2026 16:07:33 GMT
• Is Immunome’s (IMNM) Russell Exit Quietly Recasting Its Shareholder Base And Liquidity Story? simplywall.st Thu, 02 Jul 2026 05:44:07 GMT
• Form 144 Immunome For: 30 June By Investing.com Investing.com Nigeria Tue, 30 Jun 2026 21:57:39 GMT
• Immunome (IMNM) After Russell Index Removal Still Looks Cheap On Fair Value simplywall.st Tue, 30 Jun 2026 07:00:00 GMT
• Immunome CMO Robert Lechleider sells $1.09m in stock By Investing.com Investing.com Nigeria Mon, 29 Jun 2026 21:57:54 GMT
• Form 4 Immunome Inc For: 29 June By Investing.com Investing.com Nigeria Mon, 29 Jun 2026 21:22:23 GMT
• immunome insider sold shares worth $1,091,662, according to a recent sec filing marketscreener.com Mon, 29 Jun 2026 21:12:10 GMT
• immunome inc. (imnm) holds steady near support amid low volatility - stop run dars.gov.et Mon, 29 Jun 2026 15:38:30 GMT
• Immunome, Inc.(NasdaqCM:IMNM) dropped from Russell Microcap Growth Benchmark Index marketscreener.com Mon, 29 Jun 2026 12:16:25 GMT
• Immunome (IMNM) CMO sells 55K shares after exercising options Stock Titan Mon, 29 Jun 2026 07:00:00 GMT
• Immunome, Inc.(NasdaqCM: IMNM) dropped from Russell Microcap Index marketscreener.com Mon, 29 Jun 2026 05:41:58 GMT
• (imnm) price dynamics and execution-aware positioning Stock Traders Daily Sat, 27 Jun 2026 03:44:02 GMT
• Form 144 Immunome Inc. For: 25 June By Investing.com Investing.com Nigeria Thu, 25 Jun 2026 16:00:03 GMT
• does immunome's (imnm) new im-1617 trial reveal its real antibody-drug conjugate ambitions? simplywall.st Wed, 24 Jun 2026 05:37:29 GMT
• does immunome's (imnm) new im-1617 trial reveal its real antibody-drug conjugate ambitions? Sahm Tue, 23 Jun 2026 07:00:00 GMT
• immunome inc (imnm) technical analysis: support, resistance, indicators & moving averages TradingKey Tue, 23 Jun 2026 07:00:00 GMT
• immunome (imnm) stock could be below fair value after phase 1 trial start simplywall.st Sat, 20 Jun 2026 21:22:47 GMT
• immunome stock - long-term pipeline and business model under review Ad-hoc-news.de Sat, 20 Jun 2026 17:24:32 GMT
• immunome inc (imnm) valuation: pe, pb & fair value analysis TradingKey Fri, 19 Jun 2026 07:20:18 GMT
• immunome inc (imnm) risk assessment: volatility, financial risk & investment risk TradingKey Fri, 19 Jun 2026 07:19:09 GMT
• immunome inc (imnm) technical analysis: support, resistance, indicators & moving averages TradingKey Fri, 19 Jun 2026 06:04:23 GMT
• immunome inc (imnm) earnings forecast: future eps & revenue growth estimates TradingKey Fri, 19 Jun 2026 03:36:43 GMT
• immunome inc (imnm) financial health: profitability & balance sheet analysis TradingKey Fri, 19 Jun 2026 01:49:41 GMT
• immunome inc (imnm) revenue breakdown: business segments, regional revenue & profit contribution TradingKey Thu, 18 Jun 2026 05:51:54 GMT
• immunome inc (imnm) dividends & stock splits: historical payouts and event timeline TradingKey Thu, 18 Jun 2026 05:20:28 GMT
• immunome cfo max rosett sells $1.09m in stock by investing.com Investing.com India Thu, 18 Jun 2026 00:59:18 GMT
• immunome cfo max rosett sells $1.09m in stock by investing.com Investing.com UK Wed, 17 Jun 2026 21:32:00 GMT
• Immunome (IMNM) CFO uses options, sells 60,000 shares under 10b5-1 plan Stock Titan Wed, 17 Jun 2026 07:00:00 GMT
• immunome inc (imnm) earnings forecast: future eps & revenue growth estimates TradingKey Wed, 17 Jun 2026 07:00:00 GMT
• (imnm) as a liquidity pulse for institutional tactics Stock Traders Daily Tue, 16 Jun 2026 02:32:02 GMT
• how immunome’s first-in-human im-1617 adc trial at immunome (imnm) has changed its investment story simplywall.st Mon, 15 Jun 2026 20:17:47 GMT
• IMNM (NASDAQ: IMNM) director plans to sell 60,000 shares via option Stock Titan Mon, 15 Jun 2026 07:00:00 GMT
• immunome (imnm) 2026 meeting: directors elected, pay and auditor votes pass Stock Titan Fri, 12 Jun 2026 20:05:29 GMT
• imnm reiterated by wedbush -- price target maintained at $31 GuruFocus Fri, 12 Jun 2026 15:27:32 GMT
• Immunome (IMNM) director-linked entity awarded 9,897 stock options at $18.16 strike Stock Titan Fri, 12 Jun 2026 07:00:00 GMT
• Immunome (IMNM) director granted stock options on 9,897 common shares Stock Titan Fri, 12 Jun 2026 07:00:00 GMT
• J.P. Morgan Maintains Immunome(IMNM.US) With Buy Rating, Maintains Target Price $39 Moomoo Fri, 12 Jun 2026 07:00:00 GMT
• immunome (imnm) director receives 9,897 stock options at $18.16 strike price Stock Titan Fri, 12 Jun 2026 07:00:00 GMT
• immunome | 4: statement of changes in beneficial ownership of securities-director schafer carol Moomoo Fri, 12 Jun 2026 07:00:00 GMT
• immunome (imnm) director carol schafer receives grant of 9,897 stock options Stock Titan Fri, 12 Jun 2026 07:00:00 GMT
• craig-hallum maintains immunome(imnm.us) with buy rating, maintains target price $36 Moomoo Thu, 11 Jun 2026 14:31:00 GMT
• experimental cancer drug im-1617 starts testing in patients with advanced tumors Stock Titan Thu, 11 Jun 2026 11:30:00 GMT
• Immunome Doses First Patient in Phase 1 Trial of Potential First-in-Class ADC IM-1617 for Advanced Solid Tumors BioPharm International Thu, 11 Jun 2026 07:00:00 GMT
• Immunome Announces First Patient Dosed in Phase 1 Trial Evaluating IM-1617, a Potential First-in-Class ADC, in Patients with Advan... Business Wire Thu, 11 Jun 2026 07:00:00 GMT
• lifesci capital maintains immunome(imnm.us) with buy rating, maintains target price $40 Moomoo Thu, 11 Jun 2026 07:00:00 GMT
• immunome doses first patient in im-1617 cancer therapy trial by investing.com Investing.com UK Thu, 11 Jun 2026 07:00:00 GMT
• immunome director bienaime sells $203k, buys $204k in same-day trades Investing.com India Wed, 10 Jun 2026 07:00:00 GMT
• imnm: varegacestat shows strong efficacy as launch nears; adc pipeline and cash runway support growth TradingView Tue, 09 Jun 2026 16:20:56 GMT
• Immunome: Varegacestat Is The Beachhead, But The ADC Engine Is The Thesis (NASDAQ:IMNM) Seeking Alpha Tue, 09 Jun 2026 07:00:00 GMT
• Immunome director Bienaime sells $203k, buys $204k in same-day trades Investing.com Tue, 09 Jun 2026 07:00:00 GMT
• immunome (imnm) director offsets 10,500-share buy and sale in form 4 Stock Titan Tue, 09 Jun 2026 07:00:00 GMT
• transcript : immunome, inc. presents at goldman sachs 47th annual global healthcare conference 2026, jun-09-2026 10 marketscreener.com Tue, 09 Jun 2026 07:00:00 GMT
• immunome | 4: statement of changes in beneficial ownership of securities-director bienaime jean jacques Moomoo Tue, 09 Jun 2026 07:00:00 GMT
• can varegacestat’s broad efficacy profile redefine immunome’s (imnm) rare oncology investment narrative? simplywall.st Sun, 07 Jun 2026 07:00:00 GMT
• immunome earnings up next: cash burn eyed after nda filing by investing.com Investing.com UK Fri, 05 Jun 2026 11:55:50 GMT
• immunome (imnm) is down 12.7% after phase 3 varegacestat data and fda nda filing - has the bull case changed? Yahoo Finance Fri, 05 Jun 2026 02:13:00 GMT
• Immunome (IMNM) Is Down 12.7% After Phase 3 Varegacestat Data And FDA NDA Filing - Has The Bull Case Changed? Yahoo Finance Thu, 04 Jun 2026 07:00:00 GMT
• immunome reports inducement grants under nasdaq listing rule 5635(c)(4) Business Wire Thu, 04 Jun 2026 07:00:00 GMT
• a look at immunome (imnm) valuation after new barclays overweight coverage Sahm Mon, 01 Jun 2026 18:42:26 GMT
• h.c. wainwright maintains immunome(imnm.us) with buy rating, maintains target price $40 Moomoo Mon, 01 Jun 2026 11:33:00 GMT
• barclays maintains immunome(imnm.us) with buy rating, maintains target price $36 Moomoo Mon, 01 Jun 2026 09:33:00 GMT
• piper sandler maintains immunome(imnm.us) with buy rating, maintains target price $33 Moomoo Mon, 01 Jun 2026 07:00:00 GMT
• immunome announces ringside trial met primary, secondary endpoints TipRanks Sun, 31 May 2026 13:47:17 GMT
• a look at immunome (imnm) valuation after new barclays overweight coverage simplywall.st Sun, 31 May 2026 07:00:00 GMT
• immunome (imnm) reveals promising results in phase 3 trial of va GuruFocus Sun, 31 May 2026 07:00:00 GMT
• immunome’s varegacestat phase 3 ringside trial results presented at asco 2026 show progression-free survival data in desmoid tumor... geneonline.com Sat, 30 May 2026 12:53:26 GMT
• immunome announced positive clinical trial results for its drug varegacestat. Bitget Sat, 30 May 2026 12:40:38 GMT
• Immunome Announces Detailed Phase 3 RINGSIDE Data for Varegacestat in Adults with Progressing Desmoid Tumors at the 2026 ASCO Annu... Business Wire Sat, 30 May 2026 07:00:00 GMT
• Immunome Says Varegacestat Treatment Resulted In Statistically Significant Improvements In Primary And All Key Secondary Efficacy ... TradingView Sat, 30 May 2026 07:00:00 GMT
• Immunome presents phase 3 trial results for desmoid tumor drug Investing.com Sat, 30 May 2026 07:00:00 GMT
• immunome announced positive clinical trial results for its drug varegacestat. Bitget Fri, 29 May 2026 21:27:23 GMT
• immunome (imnm) receives a new rating from barclays The Globe and Mail Fri, 29 May 2026 09:28:00 GMT
• does barclays’ bullish stance refocus immunome’s (imnm) investment narrative on its adc platform? Sahm Fri, 29 May 2026 07:00:00 GMT
• imnm maintained by truist securities -- price target raised to $37 GuruFocus Thu, 28 May 2026 21:28:07 GMT
• imnm initiates coverage on barclays -- rating set to overweight GuruFocus Thu, 28 May 2026 14:21:33 GMT
• truist financial initiates immunome(imnm.us) with buy rating, announces target price $37 Moomoo Thu, 28 May 2026 12:31:00 GMT
• barclays initiates immunome at overweight with $36 price target marketscreener.com Thu, 28 May 2026 11:21:46 GMT
• Barclays initiates Immunome stock coverage with overweight rating Investing.com Thu, 28 May 2026 07:00:00 GMT
• truist raises immunome stock price target on desmoid tumor drug Investing.com Thu, 28 May 2026 07:00:00 GMT
• barclays initiates coverage of immunome (imnm) with overweight recommendation MSN Thu, 28 May 2026 07:00:00 GMT
• immunome price target raised to $37.00/share from $36.00 by truist securities Moomoo Thu, 28 May 2026 07:00:00 GMT
• immunome (imnm) to present at goldman sachs global healthcare co GuruFocus Wed, 27 May 2026 19:27:02 GMT
• about us | oil & gas journal - immunome to present at the goldman sachs 47th annual global healthcare conference FinancialContent Wed, 27 May 2026 12:00:00 GMT
• immunome management to speak at goldman sachs global healthcare event Stock Titan Wed, 27 May 2026 12:00:00 GMT
• Immunome to Present at the Goldman Sachs 47th Annual Global Healthcare Conference Business Wire Wed, 27 May 2026 07:00:00 GMT
• imnm q1 2026 earnings: smaller-than-expected loss as pipeline progress continues - earnings whisper number The Legal Advocate Tue, 26 May 2026 08:47:40 GMT
• (imnm) movement as an input in quant signal sets Stock Traders Daily Sun, 24 May 2026 07:00:00 GMT
• immunome inc stock (us45254c1062): biotech investor attention after oncology pipeline update AD HOC NEWS Thu, 21 May 2026 07:00:00 GMT
• insider buying: jean bienaime acquires 5,000 shares of immunome inc (imnm) GuruFocus Tue, 19 May 2026 14:33:39 GMT
• director bienaime adds 5,000 immunome (imnm) shares in open-market buy Stock Titan Tue, 19 May 2026 07:00:00 GMT
• immunome director bienaime buys $103,500 in company stock Investing.com Tue, 19 May 2026 07:00:00 GMT
• What Offers Immunome (IMNM) a Compelling Investment Opportunity? Yahoo Finance Mon, 18 May 2026 07:00:00 GMT
• immunome inc stock (us45254c1062): oncology deal momentum keeps biotech in focus AD HOC NEWS Sun, 17 May 2026 07:24:49 GMT
• lifesci capital maintains immunome(imnm.us) with buy rating, maintains target price $40 Moomoo Sat, 16 May 2026 15:32:00 GMT
• immunome inc stock (us45254c1062): oncology deal momentum keeps investors watching AD HOC NEWS Sat, 16 May 2026 11:14:04 GMT
• imnm maintained by leerink partners -- price target lowered to $33.00 GuruFocus Fri, 15 May 2026 19:07:30 GMT
Immunome, Inc(NASDAQ:IMNM) 
Immunome, Inc., a biopharmaceutical company, discovers and develops antibody therapeutics for oncology and infectious disease. The company's lead oncology program includes IMM-ONC-01, which targets IL-38 tumor-derived immune checkpoint capable of promoting evasion of the immune system. It also devel...
Website: http://www.immunome.com
Founded: 2006
CEO: Purnanand D. Sarma
Sector: Healthcare
Industry: Biotechnology
Share this website to your friends